Prevention of Adolescent Risky Behaviors: Neural Markers of Intervention Effects
2 other identifiers
interventional
146
1 country
1
Brief Summary
Adolescence is a time of biological and behavioral changes that can lead to risky and dangerous behaviors, and African-American youth are highly vulnerable to the consequences of risky behavior, including HIV/AIDS and violence, leading to premature death. The investigators previously showed that an intervention program reduces HIV-risk vulnerability behaviors in many African-American youth. The investigators aim to measure how the program affects different regions of the brain in order to better prevent or reduce such risky behaviors among African-American youth.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 1, 2017
CompletedStudy Start
First participant enrolled
December 11, 2017
CompletedFirst Posted
Study publicly available on registry
December 12, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 10, 2025
CompletedResults Posted
Study results publicly available
January 26, 2026
CompletedJanuary 26, 2026
December 1, 2025
7.3 years
December 1, 2017
July 20, 2025
January 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in Emotional Regulation
Emotional regulation was assessed through parent and youth self-reported questionnaires using the Behavior Rating Inventory of Executive Function, Second Edition (BRIEF-2). T scores, normed for age and sex are available. T-score standardizes an individual's executive functioning difficulties relative to peers. For example, 50 is the population mean and a standard deviation of 10. Higher scores indicate more significant problems. Scores below 60 are within normal limits; 60-64: subclinical difficulties; 65-69: mildly elevated; 70-74: moderately elevated; and 75 or above: considered highly elevated, suggesting significant difficulties in emotion regulation. These questionnaires were administered at baseline (before intervention) and 3 months post-intervention. Because parent report may be less biased regarding youth's regulation, we used parent data for analysis. Data imputation was done for missing data.
18 weeks (from pre-intervention to 3-months after post-intervention)
Secondary Outcomes (1)
Changes in Cognitive Regulation
18 weeks (from pre-intervention to 3-months after post-intervention)
Study Arms (2)
Pathways for African-Americans' Success
EXPERIMENTALSubjects will complete a 6-week Pathways for African-Americans' Success (PAAS) intervention. This is a weekly, 1.5 hour/session, family intervention for 6 weeks.
Wait-list
NO INTERVENTIONSubjects will be on waiting list for active intervention and will receive the PAAS intervention at the end of the study (same as active intervention).
Interventions
PAAS is a 6-week, technology-delivered, family-based youth risk intervention program. PAAS includes 6 sessions for parents and youth, and joint sessions in which they both engage on the same computer to integrate and practice the skills they have just learned in their separate sessions. Each session includes a review, a virtual discussion, and observing and interacting with four parent and four youth Avatars that reflect phenotypes of African Americans (AA), with voice-overs by AA parents and youth. Videos portraying family interactions and intrapersonal processes are integrated into each session to convey key points of the intervention along with interactive activities to promote skill-building and to reinforce learning. PAAS also includes a technology tutorial and an introductory session.
Eligibility Criteria
You may qualify if:
- Subject is of African-American racial status (self-reported)
- Subject can speak and read English
- Subject and parent/legal guardian agree to participate in the 6-week PAAS program
- Subject and parent/legal guardian agree to complete all assessments
- Subject must meet MRI safety eligibility
You may not qualify if:
- Subject has a major medical problem (e.g. neurological disorders)
- Subject is on medication(s) that affects the central nervous system
- Subject has behavioral/emotional problems at a clinical level (parent and/or youth report)
- Subject is pregnant or suspected of being pregnant (based on pregnancy test)
- Subject is color-blind
- Subject has claustrophobia
- Subject has metallic implants
- Subject drinks alcohol in the week prior to entry into the study (based on urine drug screen)
- Subject uses drugs in the week prior to entry into the study (based on urine drug screen)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California, Irvine
Irvine, California, 92617, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Trial was completed successfully.
Results Point of Contact
- Title
- Dr. Uma Rao
- Organization
- University of California, Irvine
Study Officials
- PRINCIPAL INVESTIGATOR
Uma Rao, MD
University of California, Irvine
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 1, 2017
First Posted
December 12, 2017
Study Start
December 11, 2017
Primary Completion
March 31, 2025
Study Completion
April 10, 2025
Last Updated
January 26, 2026
Results First Posted
January 26, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share